or Try an Advanced Search...

    Technical Analysis for YS - YS Biopharma Co., Ltd.

    Grade Last Price % Change Price Change
    C 1.03 4.24% 0.04
    YS closed up 4.24 percent on Wednesday, May 15, 2024, on 46 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical YS trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Overbought Strength 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.24%
    NR7 Range Contraction 4.24%
    Upper Bollinger Band Walk Strength 4.24%
    Older End-of-Day Signals for YS ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 14 hours ago
    Down 3% about 14 hours ago
    Fell Below Previous Day's Low about 14 hours ago
    Down 2 % about 14 hours ago
    Down 1% about 14 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    YS Chart by TradingView
    Basic chart:

    Profile

    YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Infectious Diseases Vaccines Influenza Coronavirus Hepatitis B Vaccination Shingles Rabies Vaccine Preventable Diseases

    Is YS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 YS Biopharma appoints Dave Chenn as interim CEO
    May 7 YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
    May 7 With 80% ownership, YS Biopharma Co., Ltd. (NASDAQ:YS) insiders have a lot riding on the company's future
    Apr 22 YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript
    Apr 18 YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
    Apr 16 YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
    Apr 9 YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
    Apr 3 YS Biopharma announces full repayment of $40M loan facility
    Apr 3 YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
    Mar 5 YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
    See more YS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.78
    52 Week Low 0.351
    Average Volume 158,220
    200-Day Moving Average 0.70
    50-Day Moving Average 0.78
    20-Day Moving Average 0.83
    10-Day Moving Average 0.88
    Average True Range 0.10
    RSI (14) 67.00
    ADX 27.15
    +DI 20.22
    -DI 19.94
    Chandelier Exit (Long, 3 ATRs) 0.73
    Chandelier Exit (Short, 3 ATRs) 1.00
    Upper Bollinger Bands 1.02
    Lower Bollinger Band 0.64
    Percent B (%b) 1.02
    BandWidth 46.75
    MACD Line 0.06
    MACD Signal Line 0.04
    MACD Histogram 0.0204
    Fundamentals Value
    Market Cap 95.85 Million
    Num Shares 93.1 Million
    EPS -0.57
    Price-to-Earnings (P/E) Ratio -1.81
    Price-to-Sales 0.07
    Price-to-Book 0.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.23
    Resistance 3 (R3) 1.20 1.12 1.19
    Resistance 2 (R2) 1.12 1.07 1.13 1.18
    Resistance 1 (R1) 1.07 1.04 1.10 1.10 1.17
    Pivot Point 0.99 0.99 1.00 1.00 0.99
    Support 1 (S1) 0.94 0.94 0.97 0.97 0.89
    Support 2 (S2) 0.86 0.91 0.87 0.88
    Support 3 (S3) 0.81 0.86 0.87
    Support 4 (S4) 0.84